NEUROSENSE THERAPEUTICS LTD
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for NEUROSENSE THERAPEUTICS LTD *W EXP 11/10/202, CUSIP M74240116.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for NEUROSENSE THERAPEUTICS LTD *W EXP 11/10/202, CUSIP M74240116.